Meet Relief Therapeutics at #Sachs_ELSF
— Sachs Associates (@SachsAssociates) February 1, 2023
More info @ https://t.co/hgPC4hy6UF#Sachs_ELSF #SSLSW #lifesciences #partnering #bd #licensing #health #investment #startup #healthcare #innovation #biotech #business #invest #medicine #venturecapital #hybrid #hybridevent #venturecapital pic.twitter.com/XHsXNT8sRp